title: [Toxoplasmosis and pregnancy].
abstract: Toxoplasmosis is the most common etiology of posterior uveitis. Toxoplasma gondii infection during pregnancy means either primary infection and risk of congenital toxoplasmosis or acute retinochoroiditis in a pregnant woman (risk of transmission, severity of injuries, therapeutics). Ingestion or manipulation of raw or undercooked meat is responsible for most contaminations (one- to two-thirds) in pregnant women. Toxoplasmosis seroprevalence is high in Europe, up to 54 % in southern European countries. Primary prevention advice is proposed to immunocompetent pregnant women who are seronegative for toxoplasmosis. The risk of transplacental transmission congenital toxoplasmosis during pregnancy is analyzed. The ocular lesions include retinochoroiditis and a number of other lesions. The departments of ophthalmology and of parasitology of Croix-Rousse University Hospital (Hospices Civils de Lyon) is currently following one of the largest cohorts of children infected with T. gondii (430 children alive in 2005). Our overall transmission rate during primary infection was 30 %. Retinochoroiditis incidence was 24 % in our prospective cohort. During follow-up, recurrences appeared in 29 % of cases. Acute toxoplasmic retinochoroiditis in pregnancy could be a risk of transplacental transmission due to potential parasitemia. Practices in cases of suspected or proved congenital infection are discussed. The antiparasitic drugs authorized during pregnancy are azithromycin and pyrimethamine. Azithromycin can be used alone but an association with pyrimethamine during the second trimester is useful in case of macular threat.
authors.affiliation: Service d'ophtalmologie, centre hospitalier universitaire de la Croix-Rousse, université Claude-Bernard, 103, Grande-Rue-de-la-Croix-Rousse, 69317 Lyon cedex 04, Lyon. kodjikian.laurent@wanadoo.fr
authors.forename: L
authors.initials: L
authors.lastname: Kodjikian
mesh_terms: D005260:Female; D006801:Humans; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000628:therapy; D014123:Toxoplasmosis / Q000453:epidemiology / Q000628:therapy; D014125:Toxoplasmosis, Congenital / Q000628:therapy